WealthOne’s Inspire Medical Systems INSP Stock Holding History

WealthOne’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-640	Closed	-$27K	–	298
2018 Q4	$27K	Buy	+640	New	+$27.2K	0.02%	239

Other funds holding INSP

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

WealthOne's INSP Position: Q1 2019 in Review

WealthOne sold out of Inspire Medical Systems (INSP) in Q1 2019, closing a stake of 640 shares — an estimated $27K sold.

WealthOne first reported a position in INSP in Q4 2018 and held it in 1 quarter. The position peaked at $27K in Q4 2018. 143 funds tracked by Wall St. Rank hold INSP as of Q1 2019.

WealthOne reported no remaining Inspire Medical Systems position as of Q1 2019 after selling out during the quarter.
WealthOne sold 640 Inspire Medical Systems shares in Q1 2019, an estimated $27K.
WealthOne first reported a position in Inspire Medical Systems in Q4 2018 and held it in 1 quarter.
WealthOne's Inspire Medical Systems position peaked at $27K in Q4 2018.
143 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2019.

Based on WealthOne's 13F filing for Q1 2019, filed 16 May 2019.